Biochips Market worth $21.36 billion by 2030 with 8.8% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 24, 2025 /PRNewswire/ -- The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01...
DNA
Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting
Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing patient care and accelerating drug...
Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells
Findings expand Telomir-1's oncology profile into cancers of the blood, adding to previously reported activity in triple-negative breast, pancreatic, and...
Healthcare RCM Leaders Say AI Ambitions Are Running Ahead of Data Reality
149 revenue cycle executives report data quality, documentation, and EHR integration as the real constraints on AI-not algorithms or tools...
Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation
Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory...
Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation
Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory...
Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer
Veteran CFO appointment underscores the Company’s commitment to building a strong leadership team as it advances its clinical and commercial...
23andMe Research Institute Helps Reconnect African Diaspora to Their Roots with Release of 250+ High-Resolution African Genetic Groups
Major Scientific Expansion Provides the Most Detailed Look at African Ancestry on the Market, Helping to Bypass Historical 'Brick Walls'...
4DMT to Participate in 8th Annual Evercore Healthcare Conference
EMERYVILLE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage...
Konica Minolta Healthcare Reinforces Leadership in Advanced Radiography with Seven Scientific Presentations on Dynamic Digital Radiography at RSNA 2025
Dynamic Digital Radiography pulmonary Konica Minolta's IWS workstation processes and quantifies Dynamic Digital Radiography diaphragmatic motion data. WAYNE, N.J., Nov....
Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference
SAN MATEO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel...
10k Science, an NIH-funded platform for science education, launches a new VR experience on UC Davis research into non-opioid pain relief
OAKLAND, Calif., Nov. 19, 2025 /PRNewswire/ -- Today, educational software company Dynamoid announced the launch of the 10k Science immersive 3D...
Helping Families Navigate I/DD Services funded by Medicaid- 10,000 Users and Counting
PALATINE, Ill., Nov. 19, 2025 /PRNewswire/ -- The IDD Navigator platform, launched by Little City with funding from The Coleman Foundation,...
DeepView™ System Featured at 2025 US Burn Conferences
DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence...
Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges
Teva Launches Teva Rise Teva Launches Rise - Global Open Innovation Platform First cohort features 7 real-world challenges across R&D,...
EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration
– No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show...
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology...
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free...
Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights
IRVINE, Calif., Nov. 18, 2025 /PRNewswire/ -- Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic...
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
– Partnership focuses on "kitted" tests in ex-U.S. markets, enabling accelerated access through a decentralized model – – Deal potentially...